Modulation of TLR4, hBD-2, and hBD-3 expression and hepatic tissue response by systemic probiotics in experimental apical periodontitis in rats
DOI:
https://doi.org/10.1590/Keywords:
Apical periodontitis, Probiotics, Toll-like receptor, Beta-defensins, LiverAbstract
Apical periodontitis is characterized by a robust inflammatory response and activation of innate immunity. Probiotics have been proposed as modulators of this response, but their local and systemic effects remain unclear. Objective To evaluate whether systemic supplementation with L. rhamnosus LR-04 and L. acidophilus LA-14 modulates the expression of TLR4, hBD-2, and hBD-3 in a rat model of experimental apical periodontitis (AP), and to assess potential histopathological alterations in the liver. Methodology Twenty-four male Wistar rats were randomly allocated into three groups (n=8): control (AP + water), AP + L. rhamnosus LR-04, and AP + L. acidophilus LA-14. AP was induced by exposing the pulp chambers of the first mandibular molars for 30 days. From the day of induction, probiotics (109 CFU/day via oral gavage) or water (control) were administered daily. After 30 days, the rats were euthanized. Mandibles were processed for immunohistochemical analysis of hBD-2, hBD-3, and TLR4 expression, which was assessed semi-quantitatively. Liver samples were collected, fixed, and stained with hematoxylin-eosin for histopathological evaluation of lobular inflammation, necrosis, portal inflammation, and fibrosis. Data were analyzed using the nonparametric Kruskal–Wallis test at a 5% significance level. Results No hepatic histopathological alterations were observed in any group. Probiotic supplementation resulted in significantly greater hBD-2 immunoreactivity in periapical tissues compared to the control group (P<0.05). hBD-3 expression was significantly higher in the L. acidophilus LA-14 group than in both the control and L. rhamnosus LR-04 groups (P<0.05). TLR4 expression in periapical lesions was increased in both probiotic groups relative to control (P<0.05). Conclusion Systemic supplementation with L. rhamnosus LR-04 and L. acidophilus LA-14 enhanced the local immune response in apical periodontitis, as evidenced by upregulation of TLR4, hBD-2, and hBD-3, without inducing detectable hepatic histopathological alterations.
Downloads
References
1- Ferraz DC, Dotto ME, Vieira WA, Paranhos LR, Moura CC. Apical periodontitis and systemic health: a bibliometric analysis of the top 100 most-cited publications. J Endod. 2025;51(3):268-78. doi: 10.1016/j.joen.2024.12.016
» https://doi.org/10.1016/j.joen.2024.12.016
2- Silva JA, Capalbo LC, Dal-Fabbro R, Oliveira Sales-Junior R, Moura Pereira B, Ervolino E, et al. Oral green and red propolis attenuate bone resorption and inflammation in experimental apical periodontitis. Arch Oral Biol. 2026;182:106479. doi: 10.1016/j.archoralbio.2025.106479
» https://doi.org/10.1016/j.archoralbio.2025.106479
3- Cosme-Silva L, Dal-Fabbro R, Lima Pontes F, Capalbo LC, Ervolino E, Cintra LT, et al. Multi-strain probiotic formula modulates expression of beta-defensin-2, beta-defensin-3, and TLR-4 in male rats with apical periodontitis. Arch Oral Biol. 2025;170:106137. doi: 10.1016/j.archoralbio.2024.106137
» https://doi.org/10.1016/j.archoralbio.2024.106137
4- Dal-Fabbro R, Yu M, Mei L, Sasaki H, Schwendeman A, Bottino MC. Synthetic high-density lipoprotein (sHDL): a bioinspired nanotherapeutics for managing periapical bone inflammation. Int J Oral Sci. 2024;16(1):50. doi: 10.1038/s41368-024-00316-w
» https://doi.org/10.1038/s41368-024-00316-w
5- Elkholy SE, Maher SA, Abd El-Hamid NR, Elsayed HA, Hassan WA, Abdelmaogood AK, et al. The immunomodulatory effects of probiotics and azithromycin in dextran sodium sulfate-induced ulcerative colitis in rats via TLR4-NF-?B and p38-MAPK pathway. Biomed Pharmacother. 2023;165:115005. doi: 10.1016/j.biopha.2023.115005
» https://doi.org/10.1016/j.biopha.2023.115005
6- Joly S, Maze C, McCray PB Jr, Guthmiller JM. Human beta-defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms. J Clin Microbiol. 2004;42(3):1024-9. doi: 10.1128/JCM.42.3.1024-1029.2004
» https://doi.org/10.1128/JCM.42.3.1024-1029.2004
7- Cosme-Silva L, Dal-Fabbro R, Cintra LT, Ervolino E, Prado AS, Oliveira DP, et al. Dietary supplementation with multi-strain formula of probiotics modulates inflammatory and immunological markers in apical periodontitis. J Appl Oral Sci. 2021;29:e20210483. doi: 10.1590/1678-7757-2020-0483
» https://doi.org/10.1590/1678-7757-2020-0483
8- Cosme-Silva L, Dal-Fabbro R, Cintra LT, Santos VR, Duque C, Ervolino E, et al. Systemic administration of probiotics reduces the severity of apical periodontitis. Int Endod J. 2019;52(12):1738-49. doi: 10.1111/iej.13192
» https://doi.org/10.1111/iej.13192
9- Cintra LT, Gomes MS, Silva CC, Faria FD, Benetti F, Cosme-Silva L, et al. Evolution of endodontic medicine: a critical narrative review of the interrelationship between endodontics and systemic pathological conditions. Odontology. 2021;109(4):741-69. doi: 10.1007/s10266-021-00636-x
» https://doi.org/10.1007/s10266-021-00636-x
10- Cantiga-Silva C, Estrela C, Segura-Egea JJ, Azevedo JP, Oliveira PH, Cardoso CB, et al. Inflammatory profile of apical periodontitis associated with liver fibrosis in rats: histological and immunohistochemical analysis. Int Endod J. 2021;54(8):1353-61. doi: 10.1111/iej.13519
» https://doi.org/10.1111/iej.13519
11- Ye L, Cao L, Song W, Yang C, Tang Q, Yuan Z. Interaction between apical periodontitis and systemic disease (review). Int J Mol Med. 2023;52(1):60. doi: 10.3892/ijmm.2023.5263
» https://doi.org/10.3892/ijmm.2023.5263
12- Dal-Fabbro R, Marques-de-Almeida M, Cosme-Silva L, Capalbo LC, Ervolino E, Cintra LT, et al. Effects of different alcohol concentrations on the development of apical periodontitis in rats. Arch Oral Biol. 2019;108:104538. doi: 10.1016/j.archoralbio.2019.104538
» https://doi.org/10.1016/j.archoralbio.2019.104538
13- Dal-Fabbro R, Cosme-Silva L, Rezende Silva Martins de Oliveira F, Capalbo LC, Plazza FA, Ervolino E, et al. Effect of red wine or its polyphenols on induced apical periodontitis in rats. Int Endod J. 2021;54(12):2276-89. doi: 10.1111/iej.13633
» https://doi.org/10.1111/iej.13633
14- Dal-Fabbro R, Marques-de-Almeida M, Cosme-Silva L, Ervolino E, Cintra LT, Gomes-Filho JE. Chronic alcohol consumption increases inflammation and osteoclastogenesis in apical periodontitis. Int Endod J. 2019;52(3):329-36. doi: 10.1111/iej.13014
» https://doi.org/10.1111/iej.13014
15- Cintra LT, Samuel RO, Azuma MM, Queiroz AO, Ervolino E, Sumida DH, et al. Multiple apical periodontitis influences serum levels of cytokines and nitric oxide. J Endod. 2016;42(5):747-51. doi: 10.1016/j.joen.2016.01.022
» https://doi.org/10.1016/j.joen.2016.01.022
16- Ricoldi MS, Furlaneto FA, Oliveira LF, Teixeira GC, Pischiotini JP, Moreira AL, et al. Effects of the probiotic Bifidobacterium animalis subsp. lactis on the non-surgical treatment of periodontitis. A histomorphometric, microtomographic and immunohistochemical study in rats. PLoS One. 2017;12(6):e0179946. doi: 10.1371/journal.pone.0179946
» https://doi.org/10.1371/journal.pone.0179946
17- Azuma MM, Gomes-Filho JE, Prieto AK, Samuel RO, Lima VM, Sumida DH, et al. Diabetes increases interleukin-17 levels in periapical, hepatic, and renal tissues in rats. Arch Oral Biol. 2017;83:230-55. doi: 10.1016/j.archoralbio.2017.08.001
» https://doi.org/10.1016/j.archoralbio.2017.08.001
18- Schepper JD, Collins FL, Rios-Arce ND, Raehtz S, Schaefer L, Gardinier JD, et al. Probiotic Lactobacillus reuteri prevents postantibiotic bone loss by reducing intestinal dysbiosis and preventing barrier disruption. J Bone Miner Res. 2019;34(4):681-98. doi: 10.1002/jbmr.3635
» https://doi.org/10.1002/jbmr.3635
19- Bohora A, Kokate S. Evaluation of the role of probiotics in endodontic treatment: a preliminary study. J Int Soc Prev Community Dent. 2017;7(1):46-51. doi: 10.4103/2231-0762.200710
» https://doi.org/10.4103/2231-0762.200710
20- Kobayashi R, Kobayashi T, Sakai F, Hosoya T, Yamamoto M, Kurita-Ochiai T. Oral administration of Lactobacillus gasseri SBT2055 is effective in preventing Porphyromonas gingivalis -accelerated periodontal disease. Sci Rep. 2017;7(1):545. doi: 10.1038/s41598-017-00623-9
» https://doi.org/10.1038/s41598-017-00623-9
21- Cheng L, Shi J, Peng H, Tong R, Hu Y, Yu D. Probiotics and liver fibrosis: an evidence-based review of the latest research. J Funct Foods. 2023;109:105773. doi: 10.1016/j.jff.2023.105773
» https://doi.org/10.1016/j.jff.2023.105773
22- Fusco A, Savio V, Cammarota M, Alfano A, Schiraldi C, Donnarumma G. Beta-defensin-2 and beta-defensin-3 reduce intestinal damage caused by Salmonella typhimurium modulating the expression of cytokines and enhancing the probiotic activity of Enterococcus faecium. J Immunol Res. 2017;2017:6976935. doi: 10.1155/2017/6976935
» https://doi.org/10.1155/2017/6976935
23- Harder J, Bartels J, Christophers E, Schroder JM. Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. J Biol Chem. 2001;276(8):5707-13. doi: 10.1074/jbc.M008557200
24- Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol. 2003;3(9):710-20. doi: 10.1038/nri1180
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
Todo o conteúdo do periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons do tipo atribuição CC-BY.